These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
291 related articles for article (PubMed ID: 33133722)
1. Heterogeneity of Tumors in Breast Cancer: Implications and Prospects for Prognosis and Therapeutics. Tuasha N; Petros B Scientifica (Cairo); 2020; 2020():4736091. PubMed ID: 33133722 [TBL] [Abstract][Full Text] [Related]
2. Breast cancer stem cells and the challenges of eradication: a review of novel therapies. Saeg F; Anbalagan M Stem Cell Investig; 2018; 5():39. PubMed ID: 30498750 [TBL] [Abstract][Full Text] [Related]
9. Targeting cancer stem cells and signaling pathways by phytochemicals: Novel approach for breast cancer therapy. Dandawate PR; Subramaniam D; Jensen RA; Anant S Semin Cancer Biol; 2016 Oct; 40-41():192-208. PubMed ID: 27609747 [TBL] [Abstract][Full Text] [Related]
10. Breast Cancer Stem Cells as Drivers of Tumor Chemoresistance, Dormancy and Relapse: New Challenges and Therapeutic Opportunities. De Angelis ML; Francescangeli F; Zeuner A Cancers (Basel); 2019 Oct; 11(10):. PubMed ID: 31619007 [TBL] [Abstract][Full Text] [Related]
11. Cancer stem cell markers: premises and prospects. Murar M; Vaidya A Biomark Med; 2015; 9(12):1331-42. PubMed ID: 26612591 [TBL] [Abstract][Full Text] [Related]
12. Nanomedicine-mediated drug targeting of cancer stem cells. Singh D; Minz AP; Sahoo SK Drug Discov Today; 2017 Jun; 22(6):952-959. PubMed ID: 28435061 [TBL] [Abstract][Full Text] [Related]
13. Nanoparticle Delivery of TWIST Small Interfering RNA and Anticancer Drugs: A Therapeutic Approach for Combating Cancer. Glackin CA Enzymes; 2018; 44():83-101. PubMed ID: 30360816 [TBL] [Abstract][Full Text] [Related]
14. Cancer stem cells and HER2 positive breast cancer: The story so far. Shah D; Osipo C Genes Dis; 2016 Jun; 3(2):114-123. PubMed ID: 30123819 [TBL] [Abstract][Full Text] [Related]
15. Cancer stem cell-targeted therapeutics and delivery strategies. Ahmad G; Amiji MM Expert Opin Drug Deliv; 2017 Aug; 14(8):997-1008. PubMed ID: 27866420 [TBL] [Abstract][Full Text] [Related]
16. Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target. Yan Y; Zuo X; Wei D Stem Cells Transl Med; 2015 Sep; 4(9):1033-43. PubMed ID: 26136504 [TBL] [Abstract][Full Text] [Related]
17. Cancer stem cells as a potential therapeutic target in breast cancer. Zhang M; Li Z; Zhang X; Chang Y Stem Cell Investig; 2014; 1():14. PubMed ID: 27358860 [TBL] [Abstract][Full Text] [Related]
18. Cancer Stem Cell Hypothesis for Therapeutic Innovation in Clinical Oncology? Taking the Root Out, Not Chopping the Leaf. Dzobo K; Senthebane DA; Rowe A; Thomford NE; Mwapagha LM; Al-Awwad N; Dandara C; Parker MI OMICS; 2016 Dec; 20(12):681-691. PubMed ID: 27930094 [TBL] [Abstract][Full Text] [Related]
19. The Metabolic Heterogeneity and Flexibility of Cancer Stem Cells. Tanabe A; Sahara H Cancers (Basel); 2020 Sep; 12(10):. PubMed ID: 32998263 [TBL] [Abstract][Full Text] [Related]
20. Delivery of therapeutics using nanocarriers for targeting cancer cells and cancer stem cells. Krishnamurthy S; Ke X; Yang YY Nanomedicine (Lond); 2015 Jan; 10(1):143-60. PubMed ID: 25597774 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]